Drug Discovery · Haddonfield, NJ · Founded 2016 · Privately Held (backing)
Developer of molecular therapeutics designed to treat cancer and skin pigmentation disorders. Linnaeus Therapeutics is based in Haddonfield, NJ and was founded in 2016. It was valued at $83.1 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $35.6 million across 8 recorded rounds; the latest was a $5 million seed round in Feb 2026.
PMV mark · valuation
$83.1M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$35.6M
Last round
Seed Round
Feb 2026
Team — not yet on record
No current team members for Linnaeus Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Linnaeus Therapeutics with a free account
·Watch Linnaeus Therapeutics: the Monday email on marks, rounds and moves
